APH vs ISPC · P/E 40, rev $23.09B vs rev $9.3M
Amphenol Corporation (APH) versus iSpecimen Inc (ISPC) — a side-by-side from cached financials, not a winner call.
Amphenol Corporation (APH) is a electronic components company listed on US.
iSpecimen Inc (ISPC) is a diagnostics & research company listed on US.
Latest reported APH revenue for 2025-12-31 was $23.09B. Net income was $4.27B. Revenue was up 51.7% from 2024-12-31 to 2025-12-31. APH currently screens at market cap $170.77B and trailing P/E 39.9.
Latest reported ISPC revenue for 2024-12-31 was $9.3M. Net income was -$12.5M. Revenue was down 6.4% from 2023-12-31 to 2024-12-31. ISPC currently screens at market cap $4.4M.
APH currently screens at market cap $170.77B and trailing P/E 39.9. ISPC currently screens at market cap $4.4M.
Not investment advice. Open the APH and ISPC stock pages for the full models.
Not investment advice.